Financial Data and Key Metrics Changes - The company reported a full-year EBITDA of $111 million, an 11% increase over 2024, with an EBITDA margin of 37% [19] - The fourth quarter EBITDA margin reached a record 42%, marking a significant improvement [5] - The company is projecting 2026 EBITDA guidance of $112 million to $118 million, indicating low double-digit growth over 2025 [5][19] Business Line Data and Key Metrics Changes - The interactive business grew revenue and EBITDA by 53% and 60% respectively in the fourth quarter [4] - The digital business accounted for 51% of EBITDA, with expectations to grow to over 60% by 2026 [19] - The company is focusing on a CapEx-light business model, which is expected to improve cash flow significantly [9] Market Data and Key Metrics Changes - The company is optimistic about expanding its footprint in North America, particularly in Illinois, where it has strong relationships with key customers [12] - iGaming is projected to be more than three times the size of sports betting in states where they compete directly, presenting a significant opportunity [18] Company Strategy and Development Direction - The company is transforming towards a higher growth, higher margin, and less capital-intensive business model [21] - A new cloud-based lottery platform has been launched, with plans to expand its market presence outside the U.S. [63] - The company is combining its gaming and leisure businesses into one reporting entity called Retail Solutions to reflect its current management structure [20] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in sustaining growth momentum, particularly in the interactive segment, with no signs of slowing down [34][70] - The company is prepared for potential impacts from tax changes in the UK, with strategies in place to mitigate effects [25] - Management remains optimistic about the company's ability to navigate challenges in the operating environment, including geopolitical factors [56] Other Important Information - The company is targeting to reduce net leverage to 2.5-3 times by year-end 2026, which may lead to lower interest rates and better financing options [6] - The company has secured long-term contracts with major customers like bet365 and Entain, ensuring a stable revenue stream [48] Q&A Session Summary Question: Impact of UK tax changes on guidance - Management indicated that customers are adjusting their RTP and bonusing structures to mitigate tax impacts, and they feel comfortable with the expected outcomes [25] Question: Capital allocation strategy amid changing valuations - Management acknowledged the potential for stock repurchase or acquisitions but emphasized a focus on deleveraging at present [28] Question: Expectations for digital business growth - Management confirmed ongoing momentum in the interactive business and highlighted opportunities in new markets like Brazil [34] Question: Retail vs. online marketing strategies - Management noted that operators are looking to balance their marketing strategies between retail and online to mitigate tax impacts [44] Question: Performance of Virtual Sports and Bet Builder product - Management reported modest growth in the Bet Builder product and acknowledged some softening in the Brazil market, but remains optimistic about margin sustainability [50]

Financial Data and Key Metrics Changes - In Q2 fiscal 2026, total sales were nearly $8 billion, a decline of 2.6% year-over-year, impacted by nearly 500 basis points from optimization actions [12][20] - Adjusted EBITDA grew by 23% to $179 million, with an adjusted EPS of $0.62, significantly up from $0.22 in the previous year [16][20] - Free cash flow increased by $50 million to $243 million, contributing to a reduction in net debt to its lowest level since fiscal 2018, with a net leverage ratio of 2.7 times [18][19] Business Line Data and Key Metrics Changes - Natural product sales grew by 7%, outperforming the market, while conventional product sales declined by 12%, primarily due to network optimization [13][14] - Retail sales fell by 8%, largely due to strategic store closures, although same-store sales improved sequentially by 100 basis points [14] Market Data and Key Metrics Changes - The overall business outperformed the market, aligning with the target addressable market's estimated low double- to single-digit growth rate [9][13] - The company is targeting a $90 billion addressable market, focusing on grocers that emphasize differentiation for sustained long-term growth [10] Company Strategy and Development Direction - The company is advancing a value creation strategy aimed at achieving profitable growth with customers and suppliers, focusing on supply chain enhancements, private brands, and technology [4][10] - The implementation of an AI-powered supply chain planning platform, Relex, is expected to improve customer service and inventory management [5][6] Management's Comments on Operating Environment and Future Outlook - Management remains confident in delivering low single-digit average sales growth for fiscal 2026 through fiscal 2028, with expectations for growth returning in fiscal 2027 [10][22] - The company is monitoring the impact of SNAP changes on consumer behavior but believes the effects are manageable and embedded in their outlook [50] Other Important Information - The company repurchased nearly 750,000 shares for approximately $25 million, reflecting confidence in long-term value creation [19] - The updated full-year outlook includes a sales range of $31 billion to $31.4 billion, a reduction from previous expectations, while Adjusted EBITDA and Adjusted EPS expectations have been increased [20][22] Q&A Session Summary Question: Impact of network optimization on conventional sales - The 500 basis points headwind from optimization was more significant than anticipated, primarily due to the exit from the Allentown facility [26][27] Question: Underlying business trends in conventional sales - Excluding optimization impacts, the underlying business showed low single-digit growth, driven by inflation and volume trends [30][31] Question: Pipeline composition for growth - The majority of the pipeline consists of incremental categories with existing customers, reflecting healthy relationships and growth opportunities [35][36] Question: Future of private brand execution - The private brands portfolio is expected to grow faster than the total business, with a focus on innovation and differentiation [94][96] Question: Management of rising diesel costs - The company has tools to manage fuel costs, including hedges and contractual protections, making the situation manageable [92][93]

Financial Data and Key Metrics Changes - Diluted earnings per share reached $3.49, a 50% increase from the prior year [6] - Net income was $130 million, up 49% from the previous year [6] - EBITDA for the quarter was $309 million, reflecting a 27.5% increase year-over-year [6] - Total revenue for the quarter was $3.91 billion, a slight increase of $12 million or 0.3% from the prior year [9] - Gross profit was $1.01 billion, an increase of $94 million or 10.3% from the prior year [10] Business Line Data and Key Metrics Changes - Inside same-store sales increased by 4% for the third quarter, with prepared food and dispensed beverages sales up 4.3% [7] - Grocery and general merchandise sales also rose by 4%, with energy drinks and nicotine alternatives showing double-digit growth [8] - Same-store gallons sold increased by 0.4%, with a fuel margin of $0.41 per gallon [8] Market Data and Key Metrics Changes - The Midcontinent region experienced a 4% decline in fuel gallons sold, indicating market share growth for the company [8] - The average retail price of fuel was $2.72 per gallon, down from $2.85 a year ago [10] Company Strategy and Development Direction - The company is focused on community support through initiatives like the Feeding America campaign [5] - A new culinary initiative involving chicken wings has been expanded to over 550 stores, aiming to complement existing offerings [17] - The company plans to release its next three-year strategic plan at an Investor Day event on June 24 [18] Management's Comments on Operating Environment and Future Outlook - Management noted that volatility in fuel prices is typical and does not significantly impact margins in the long term [21][24] - The company expects fourth-quarter operating expenses to rise in the mid-single digits, influenced by higher variable incentive compensation [16] - Management expressed confidence in the overall health of consumer shopping habits across income cohorts, with growth noted in lower-income segments [36] Other Important Information - The company maintained its quarterly dividend at $0.57 per share and repurchased approximately $76 million in shares during the quarter [14] - The company updated its fiscal 2026 guidance, expecting EBITDA to increase by 18%-20% and inside same-store sales to rise between 3.5%-4.5% [15] Q&A Session Summary Question: Impact of volatility on business - Management acknowledged that volatility is common and typically leads to compressed margins initially, but historically results in net positive margins over time [21][24] Question: Inside same-store sales and pricing impacts - Management indicated that pricing has not been a significant factor in inside sales, with minimal price increases in prepared food [26] Question: Strength in non-alcoholic beverages - Growth in non-alcoholic beverages was primarily driven by energy drinks and flavor-enhanced waters, with no significant stocking behavior noted [32] Question: Customer health across income cohorts - Management reported that all income cohorts are shopping at stores, with lower-income cohorts growing at a slower rate but showing strength in prepared foods [36] Question: Wings rollout and pricing strategy - The rollout of wings will be measured, with pricing aimed to encourage trial and adoption while maintaining a competitive edge [49] Question: Integration of Fikes and future M&A - Management confirmed that integration of Fikes is on track, and the company is positioned to pursue additional acquisitions if opportunities arise [78]

Financial Data and Key Metrics Changes - Revenue for the full year 2025 reached approximately $120 million, reflecting a 10% year-over-year growth driven by improvements in average selling price and volumes [28][29] - Adjusted EBITDA for 2025 was $13.2 million, representing a 26% improvement compared to 2024 [28][29] - Gross margin for the year was 27.9%, negatively impacted by GAC ramp-up costs [28] - Net loss in Q4 2025 was $50 million, compared to a net loss of $1.3 million in Q4 2024 [30] Business Line Data and Key Metrics Changes - The PAC business generated full-year revenues of approximately $120 million, up 10% year-over-year, with adjusted EBITDA of $13 million, a 26% improvement over 2024 [21][28] - The company is pausing GAC production to conduct a comprehensive engineering and production process optimization review, with no GAC production expected in 2026 [5][14] Market Data and Key Metrics Changes - The GAC market fundamentals remain strong, with persistent supply shortages against steady annual growth from existing demand drivers [15][16] - The company has 96% contract visibility on 2026 targeted volumes and 75% visibility through 2027 [23] Company Strategy and Development Direction - The company is focusing on optimizing its PAC business while pausing GAC production to refine its engineering and production processes [4][36] - A strategic shift towards specialty products and engineered materials commanding premium pricing has improved the business profile [23] - The company is committed to making disciplined capital allocation decisions and avoiding the sunk cost fallacy [14][36] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the GAC market opportunity, citing strong demand and pricing [15][42] - The company anticipates revenue for 2026 in the range of $120 million to $125 million, with adjusted EBITDA of $17 million to $20 million, based solely on PAC business performance [25][33] Other Important Information - The company is taking a $45 million write-down on its Corbin assets as part of its decision to switch GAC feedstock to purchased bituminous coal [16] - Significant changes to the leadership team have been made to enhance operational capabilities and address production challenges [17][19] Q&A Session Summary Question: Is there anything that would prevent the company from pursuing GAC? - Management confirmed there are no concerns about pursuing GAC due to strong market fundamentals and expected demand [42] Question: Any commentary on regulatory undercurrents affecting PAC? - Management stated there is no regulatory uncertainty affecting the PAC business, and existing regulations remain intact [44] Question: Is the company expecting to generate free cash flow for the year? - Management indicated that the PAC business is expected to generate free cash flow, with maintenance CapEx anticipated to be lower in the following year [45] Question: Can the company supply the market if there is increased demand? - Management confirmed that there is capacity to expand PAC volumes to meet increased demand without cannibalizing GAC production [46] Question: Are there any updates on the alternative applications for Corbin wet cake? - Management reported progress in testing asphalt emulsion but cautioned against expecting significant revenues from it in 2026 [63]

Financial Data and Key Metrics Changes - Revenue grew 6.1% year-over-year to $2.2 billion, driven by 5.5% organic growth and a modest contribution from an acquisition in Ireland [12] - Net income was $38.8 million or $0.64 per diluted share, compared to $43.6 million or $0.69 per share in the prior year [13] - Adjusted net income was $50.4 million or $0.83 per diluted share versus $55.3 million or $0.87 per diluted share a year ago [13] - Adjusted EBITDA was $117.8 million, compared to $120.6 million in the prior year [14] Business Line Data and Key Metrics Changes - B&I revenue was $1.1 billion for the quarter, up 4% year-over-year, with operating profit of $79.7 million and margin of 7.5% [15] - Aviation revenue grew 10% to $297.7 million, with operating profit of $12.6 million and margin of 4.2% [16] - M&D generated $422.3 million in revenue, a 7% increase year-over-year, with operating profit of $36.3 million and margin of 8.6% [17] - Education revenue rose 2% to $228.7 million, with operating profit increasing 54% to $21.6 million and margin expanding to 9.4% [18] - Technical Solutions revenue was $229.7 million, up 14% year-over-year, with operating profit of $8.4 million and margin at 3.7% [19] Market Data and Key Metrics Changes - Demand remains generally healthy across end markets, with improving transaction volumes in prime office and stabilization in Class A vacancy trends [4] - The aviation segment is supported by resilient TSA checkpoint volumes and ongoing airport infrastructure investments [5] - The semiconductor manufacturing sector is experiencing accelerated public and private investment, with a forecast of over $1.5 trillion in fabrication facility investment through 2030 [6] Company Strategy and Development Direction - The company is focused on improving consistency within Technical Solutions and executing with discipline across the enterprise [27] - The acquisition of WGNSTAR is expected to strengthen the company's presence in semiconductor fabrication environments [6] - The company anticipates full-year organic growth of 3%-4%, with specific segments expected to grow above that range [24] Management's Comments on Operating Environment and Future Outlook - Management remains cautiously optimistic about the business trajectory despite macroeconomic uncertainties [31] - The company is confident in the underlying demand environment and expects service mix to improve as projects progress [21] - Management highlighted the importance of AI in enhancing capabilities rather than disintermediating core services [10] Other Important Information - The company ended the quarter with total indebtedness of $1.7 billion and available liquidity of $608 million [22] - Free cash flow was $48.9 million, representing a significant improvement over the prior year [23] - The company repurchased 2.1 million shares at an average price of $44.13 for a total cost of $91.1 million [23] Q&A Session Summary Question: Impact of project timing and service mix on margins - Management confirmed that weather-related delays were a significant factor affecting project timing, but underlying demand remains strong [31][32] Question: Customer behavior in B&I segment - Management noted stable customer behavior with no significant requests for pricing concessions, although a large contract exit in the UK is expected to impact revenue [38][39] Question: Balancing capital deployment and de-leveraging - Management indicated that free cash flow will be used to reduce leverage back towards the target range below 3x [42] Question: Competitive dynamics in the market - Management reported no significant changes in competitive dynamics, with stability observed across the sector [49] Question: Education segment margins sustainability - Management expressed confidence in the education segment's margin profile, although some pressure is expected in the next quarter due to weather-related school closures [73][74]

Financial Data and Key Metrics Changes - Stagwell reported a 6% growth in 2025, driven by a 13% increase in digital transformation and a 6% increase in marketing services [3][4] - Adjusted EBITDA for 2025 was $422 million, with a margin of 17.4%, while adjusted EBITDA excluding advocacy surged 16% to $377 million, marking a new company record [10][23] - Free cash flow more than doubled to $187 million, representing nearly 45% conversion of adjusted EBITDA [11][25] Business Line Data and Key Metrics Changes - The Marketing Cloud segment exceeded $105 million in revenue, growing 34% organically for the full year, with a remarkable 41% organic growth in Q4 [6][21] - Digital transformation and marketing services continued to perform well, with organic growth rates of 9% and 5% respectively [4][22] - The marketing cloud grew 230% or 34.3% organically, reflecting increased adoption of its product suite [22] Market Data and Key Metrics Changes - The company anticipates approximately 10% net revenue growth in 2026, primarily organic, driven by political increases and new business [4][28] - The advocacy business is expected to benefit from a political super cycle, with over $20 billion projected to be spent in politics [5][38] - The top 25 customers grew 20% year over year, representing 29% of total revenue [6][16] Company Strategy and Development Direction - Stagwell is focusing on accelerated organic growth, market share expansion, and advanced AI applications deployment [3][5] - The company has pivoted towards AI application development, slowing down planned acquisitions to allocate capital towards this area [5][52] - A significant buyback program has been announced, with a $350 million expansion approved to enhance shareholder value [18][50] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the continuation of strong growth in digital transformation, driven by increased investments in AI [30][32] - The company is positioned to benefit from the chaos among competitors, leading to increased client turnover and organic growth opportunities [49][54] - Management expects 2026 to be transformational, with guidance for total net revenue growth of 8%-12% and adjusted EBITDA of $475 million-$525 million [28][14] Other Important Information - The Marketing Cloud generated a positive margin for the first time in Q4, reaching an adjusted EBITDA margin of 10.8% [26] - The company is implementing significant changes across operations, including AI integration for efficiency improvements [11][24] - Stagwell's capital allocation strategy remains focused on growth while maintaining cost discipline [25][27] Q&A Session Summary Question: What is the confidence in the continuation of digital transformation growth? - Management expects even stronger double-digit growth in digital transformation for 2026, driven by AI investments and business model realignment [30][32] Question: What revenue growth and EBITDA contribution are expected from The Machine and Marketing Cloud in 2026? - Management anticipates significant interest and potential revenue growth from these products, aiming for at least $25 million in the first year [33] Question: How is creative pacing amid AI disruption? - Premium creative remains in high demand, with agencies like Anomaly and 72andSunny expected to achieve record revenues [35][36] Question: What are the early trends for advocacy in 2026? - Early trends indicate strong interest in the upcoming midterm cycle, with expectations for significant expenditures [38] Question: What is the potential for incremental cost-cutting and efficiencies? - Management is working on initiatives to achieve additional cost savings, with potential upside not fully reflected in current budget guidance [41] Question: What drove the doubling of free cash flow in 2025? - Focus on cash management, faster billing, and improved collection processes contributed to the doubling of free cash flow [44][45] Question: How has the competitive environment changed post-merger of competitors? - The active pitching environment has increased, benefiting Stagwell as clients seek stability amid competitor chaos [48][49] Question: What is the expectation for share repurchase in 2026? - Management indicates a more aggressive buyback strategy, focusing on achieving fair valuation for the stock [50]

Financial Data and Key Metrics Changes - In Q4 2025, net product revenues were $22.3 million, up from $16.4 million in Q4 2024, indicating a significant increase [23] - For the full year 2025, net product revenues reached $73.6 million, compared to $69.3 million in 2024, showing stable performance [23] - Total operating expenses for Q4 2025 were $41 million, while for the full year, they were $202.9 million, reflecting a disciplined cost management approach [23] - The net loss for Q4 2025 was $6.4 million, a significant improvement from a net loss of $30.7 million in Q4 2024 [25] - The full year net loss was $142.6 million, down from $157.8 million in 2024, primarily due to reduced R&D expenses [25] Business Line Data and Key Metrics Changes - The company focused on ZYNLONTA, achieving a stable revenue stream in the third-line plus DLBCL setting, with a strong Q4 performance driven by new account activations [5][9] - The strategic reprioritization led to a reduction in operating costs by approximately 50%, enhancing the company's financial flexibility [5][8] Market Data and Key Metrics Changes - The company anticipates a peak annual revenue opportunity of $600 million to $1 billion for ZYNLONTA, contingent on regulatory approval and compendia inclusion [7][12] - The treatment landscape for DLBCL is evolving, with a current 60/40 split between complex therapies and broadly accessible therapies, indicating a competitive market environment [16] Company Strategy and Development Direction - The strategic plan focuses on optimizing lifecycle management for ZYNLONTA, including advancing LOTIS-5 and initiating LOTIS-7 [5][6] - The company aims to establish ZYNLONTA as a backbone therapy in second-line plus DLBCL, while also expanding into indolent lymphomas [6][12] - The management emphasized the importance of maintaining a strong cash position to support ongoing and future clinical trials [11][28] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving significant long-term growth starting in 2027, driven by anticipated data catalysts and regulatory approvals [28] - The company remains optimistic about the potential for ZYNLONTA to reach a broader patient population through expanded indications [12][19] Other Important Information - The company ended 2025 with a cash balance of $261 million, providing a cash runway into 2028 [26] - An amendment to the royalty purchase agreement with HealthCare Royalty was made, enhancing strategic flexibility [11] Q&A Session Summary Question: How are PFS events tracking for LOTIS-5? - Management is confident in the Q2 timing for the top-line readout and will share primary and secondary endpoints at that time [30][31] Question: Is the $200-$300 million opportunity for LOTIS-5 conservative? - Management believes the profile seen in the safety run-in supports a meaningful role in second-line plus DLBCL, with potential for higher sales if the clinical profile is favorable [35][36] Question: What is the expected R&D spend going forward? - R&D expenses are expected to decrease in 2026 and 2027, assuming the current number of trials remains stable [43][45] Question: How should capital allocation priorities be viewed? - The company is focused on driving ZYNLONTA growth and has allocated capital for ongoing trials and pre-launch activities [48][51] Question: What is the current commercial run rate for ZYNLONTA? - Management is pleased with maintaining market share despite increased competition and anticipates significant sales growth with LOTIS-5 approval [60][61]

Financial Data and Key Metrics Changes - For Q4 2025, the company reported revenue of $48.5 million, a 10.6% increase year-over-year, with an operating loss of $10.6 million due to a one-time non-cash impairment, resulting in a loss of $0.45 EPS [5][14] - Full year 2025 revenue reached $191.2 million, with over $30 million from new products less than five years old, marking a growth of 16.2% year-over-year, leading to a full year operating loss of $5.9 million, equating to a loss of $0.35 EPS [5][14] - The consolidated gross profit for Q4 was $12.1 million, up 13.7% from the previous year, with a gross margin of 24.9%, a 70 basis point improvement from the prior year [10][11] Business Line Data and Key Metrics Changes - The battery and energy product segment generated revenues of $45.9 million, a 15.1% increase from the previous year, with organic growth driven by a 39.6% increase in medical and a 20.4% increase in industrial and other commercial sectors [8][9] - The Communications Systems segment saw revenues decline to $2.6 million, a 35.2% decrease from the previous year, primarily due to delayed orders from the U.S. government [9][10] Market Data and Key Metrics Changes - The sales split between commercial and government defense for the battery business was 73/27, compared to 70/30 in the previous year, indicating a shift towards more commercial sales [9] - The backlog at the end of Q4 was $110.2 million, a 22.1% increase from the previous quarter, representing 58% of trailing twelve months sales [10] Company Strategy and Development Direction - The company aims to improve profitability in the Communications Systems business and expects new product sales to drive growth in 2026 [6][19] - Strategic initiatives include transitioning various sub-brands to the Ultralife master brand and aligning battery and energy facilities under single leadership to maximize synergies [20][21] - The focus remains on operational efficiency, vertical integration, and expanding product offerings to drive organic growth [26][27] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growth potential in 2026, citing a healthy backlog and the completion of the Electrochem transition as key factors for future success [27] - The company is targeting organic growth rates of at least double GDP and aims for EBITDA margins greater than 10% in the short term [29][30] Other Important Information - The company completed the ERP transition and various operational initiatives to reduce ongoing costs during 2025 [5][6] - The company has received a refundable tax credit for certain qualifying battery cells and packs, which is expected to positively impact future financials [13] Q&A Session Summary Question: Growth and Margin Expansion Opportunities - Management discussed the roadmap for organic growth, targeting a minimum of double GDP growth and a short-term EBITDA margin of over 10% [29] Question: Baseline Revenue for Communications Systems Business - Management defined baseline revenue for the Communications Systems business as $25 million, with potential for larger orders in the future [32] Question: Medical Order Ramp-Up - Management indicated that a new medical order represents a six-figure plus opportunity per year, with initial product launches expected soon [34]

Financial Data and Key Metrics Changes - In 2025, Exagen achieved record revenue of $66.6 million, a nearly 20% increase over 2024, driven by over 11% growth in testing volume and over 7% increase in trailing 12-month ASP [21][24] - The gross margin for 2025 was just over 58%, down from about 60% in 2024, reflecting ASP pressure in the second half of the year [23][24] - Operating expenses for 2025 were $53 million, up about 13% compared to 2024, indicating early signs of scale in the business as revenue growth outpaced expense growth [24][25] Business Line Data and Key Metrics Changes - The volume run rate increased from approximately 30,000 tests in Q1 2025 to over 35,000 tests in subsequent quarters, marking the highest Q4 testing volume in Exagen's history [12][21] - The ASP at the end of 2025 was approximately $441, up from $411 at the start of the year, reflecting successful execution in revenue cycle management and product enhancements [13][21] Market Data and Key Metrics Changes - The Pharma Services segment generated $1.7 million in revenue in 2025, significantly up from roughly $100,000 in 2024, with a backlog value of over $4 million expected to grow [23] - The company anticipates revenue for 2026 to be between $70 million and $73 million, with both volume and ASP growth contributing [19][27] Company Strategy and Development Direction - Exagen aims to own the entire autoimmune diagnostics space, focusing on comprehensive care and innovative solutions to address significant unmet needs in autoimmune disease diagnosis [6][19] - The company is prioritizing three objectives: advancing adoption through an upgraded sales force, expanding ASP through revenue cycle optimizations, and driving innovation with a structured product development cadence [20][30] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the long-term opportunity for ASP growth, driven by strategic initiatives that have improved ASP from $280 to $441 over the past three years [27][28] - The company is focused on achieving positive adjusted EBITDA and sustainable cash flow, with a breakeven revenue run rate now expected to be around $80 million [28][30] Other Important Information - Exagen has launched three sets of innovative markers into the clinic within an 18-month period, with ongoing efforts to streamline R&D and focus on high-potential projects [10][18] - The company is actively engaging with medical directors and has secured advocacy from the American College of Rheumatology, which is expected to enhance market access and support ASP growth [14][51] Q&A Session Summary Question: What is the rationale behind the recent investments and the adjusted profitability target? - Management indicated that the investments are aimed at ensuring durable cash flow positivity and enhancing the commercial organization, which is critical for long-term growth [32][34] Question: What is the status of the myositis product development? - The company is on track to have the myositis offering ready for commercialization by 2027, following internal feasibility studies and validation of assays [36] Question: How is the ASP expected to trend in 2026? - Management expects low single-digit ASP growth relative to Q4 2025 levels, with a focus on stabilizing and gradually increasing ASP throughout the year [37][60] Question: Can you provide an update on the Northwell Health situation and its impact on volume? - Management clarified that the Northwell situation was a one-time setback, and growth initiatives have compensated for any lost volume, with positive trends observed in Q4 [39][46] Question: What is the current status of the local coverage determination for rheumatologic diseases? - The local coverage determination is still in progress, and its outcome could significantly impact the company's future product offerings and market positioning [74][75]

Financial Data and Key Metrics Changes - The company ended the fourth quarter with approximately $379 million in cash equivalents and investments, exceeding internal targets for the quarter, reflecting disciplined capital management [23] - The total project costs for Project Permian are estimated to be in the range of $475 million to $575 million, which supports the project's economics [42][45] Business Line Data and Key Metrics Changes - The integrated clean power product combines two Siemens SGT-A35 gas turbines with Entropy's post-combustion carbon capture system, designed for over 90% CO2 capture, representing a significant advancement in clean power technology [11][12] - The net electrical output capacity of the plant has been increased from approximately 60 megawatts to 80 megawatts, a 33% increase in generation capacity from the same site footprint [16] Market Data and Key Metrics Changes - The forward curve for power prices in ERCOT has increased from $40-$45 per megawatt hour to $65-$70, indicating an 80% increase in wholesale power prices in West Texas [31] - There is a growing pipeline of prospective offtake relationships across industrial, utility, and data center verticals, with significant interest from hyperscale data center developers [19][20] Company Strategy and Development Direction - The company has pivoted away from Oxy-combustion as its primary near-term commercial vehicle, focusing instead on natural gas power with over 90% carbon capture, which can be executed with existing equipment [3][4] - The company aims to secure a signed offtake agreement or MOU at pricing at or above $100 per megawatt hour, which is essential for project bankability [20] Management's Comments on Operating Environment and Future Outlook - The management highlighted the urgency for clean, firm baseload power due to significant load growth projected in West Texas over the next 5-10 years, driven by AI data centers and industrial re-onshoring [5][6] - The policy environment is becoming increasingly supportive of carbon capture and storage (CCS), reinforcing the company's strategic direction [10] Other Important Information - The company is targeting a financial investment decision (FID) in the second half of 2026, with a commercial operations date aimed for early 2029, marking it as the first commercial natural gas plus CCUS project in the U.S. [17] - The partnership with Entropy is critical, as it aligns incentives and performance directly with the company's goals, enhancing the project's viability [14][15] Q&A Session Summary Question: What is the competitive landscape for the $100 per megawatt hour pricing? - Management noted that power prices have significantly increased, with new contracted capacity for firm delivery potentially exceeding $100 per megawatt hour, reflecting the importance of reliability and speed [30][32] Question: Is there potential government support for financing? - Management indicated that the current administration is supportive of solutions that enhance domestic energy supply and align with environmental goals, suggesting potential financial support from the government [34][36] Question: What are the updated project costs for Project Permian? - The estimated total project costs are in the range of $475 million to $575 million, with ongoing efforts to secure long lead equipment and manage costs effectively [40][42] Question: What is the focus on the commercial pipeline beyond Project Permian? - The company is currently focused on West Texas and Project Permian, as it presents the best economic opportunities, while still maintaining optionality around other projects [48][49] Question: What are the key characteristics that attract customers to NET Power's solution? - Management emphasized the need for speed, reliability, and carbon capture, positioning the company as a viable solution for meeting load growth while addressing environmental concerns [52][55]